Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Key Studies of Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Rapid Recap by Martin Mahoney, MD, PhD

September 29 - October 3, 2021; Virtual
Hear unique insights from expert faculty on important studies from IDWeek 2021, including new data on vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Released: November 11, 2021

Information on this Educational Activity


Martin C. Mahoney, MD, PhD

Professor of Oncology
Department of Internal Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Martin C. Mahoney, MD, PhD, has disclosed that he has received consulting fees from Merck, Pfizer, and Sanofi; fees for non-CME/CE services from GlaxoSmithKline, Merck, Pfizer, and Sanofi; and other financial or material support from Pfizer.

Program Medium

This program has been made available online.

Related Content

Hear experts discuss their approach to treating patients with infections caused by XDROs, from Clinical Care Options (CCO)

Yohei Doi Headshot Yohei Doi, MD, PhD
Program Director
Emily Heil, PharmD, MS, BCIDP, AAHIVP
Program Director
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: February 3, 2023 Expired: February 2, 2024

Dr Helen Chu shares how the COVID-19 pandemic has influenced RSV diagnostic and prevention efforts, from Clinical Care Options (CCO)

Helen Y. Chu, MD, MPH Released: January 31, 2023

Learn from Dr Zhuxin Mao about emerging data on quantifying quality of life of older adults with RSV, from Clinical Care Options (CCO)

person default Zhuxin Mao, PhD Released: January 30, 2023

Dr Emily Heil shares her approach to treating infections caused by KPC-producing bacteria, from Clinical Care Options (CCO)

Emily Heil, PharmD, MS, BCIDP, AAHIVP Released: January 3, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings